Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
E-pub ahead of print

Characterisation of the calcitonin gene-related peptide receptor antagonists ubrogepant and atogepant in human isolated coronary, cerebral and middle meningeal arteries

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Current understanding of thalamic structure and function in migraine

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Exploration of purinergic receptors as potential anti-migraine targets using established pre-clinical migraine models

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Sleep in cluster headache revisited: Results from a controlled actigraphic study

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Calcitonin-gene related peptide and disease activity in cluster headache

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Exploration of physiological and pathophysiological implications of miRNA-143 and miRNA-145 in cerebral arteries

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Exploration of purinergic receptors as potential anti-migraine targets using established pre-clinical migraine models

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Does inflammation have a role in migraine?

    Research output: Contribution to journalReviewResearchpeer-review

  4. The changing faces of migraine

    Research output: Contribution to journalEditorialResearchpeer-review

  5. Some aspects on the pathophysiology of migraine and a review of device therapies for migraine and cluster headache

    Research output: Contribution to journalReviewResearchpeer-review

  • Eloísa Rubio-Beltran
  • Ka Yi Chan
  • Ah Jan Danser
  • Antoinette MaassenVanDenBrink
  • Lars Edvinsson
View graph of relations

BACKGROUND: Migraine has been associated with a dysfunctional activation of the trigeminovascular system. Calcitonin gene-related peptide, a neuropeptide released from the trigeminal nerve fibres, has an important role in the pathophysiology of migraine and is a current therapeutic target for migraine treatment.

METHODS: We examined the effects of two novel calcitonin gene-related peptide receptor antagonists, ubrogepant and atogepant, on the relaxations induced by α calcitonin gene-related peptide in human isolated middle meningeal, cerebral and coronary arteries. Furthermore, the contractile responses to atogepant and ubrogepant per se were studied and compared to the responses elicited by zolmitriptan in proximal and distal human coronary arteries.

RESULTS: In intracranial arteries, both blockers antagonized the calcitonin gene-related peptide-induced relaxations more potently when compared to the inhibition observed in distal human coronary arteries, with atogepant showing a higher potency. When analysing their antagonistic profile in HCA, ubrogepant showed a competitive antagonist profile, while atogepant showed a non-competitive one. Neither of the gepants had vasoconstrictor effect at any of the concentrations studied in human coronary arteries, whereas zolmitriptan elicited concentration-dependent contractions.

CONCLUSION: ubrogepant and atogepant differentially inhibit the calcitonin gene-related peptide-dependent vasodilatory responses in intracranial arteries when compared to distal human coronary arteries. Also, both gepants are devoid of vasoconstrictive properties in human coronary arteries.

Original languageEnglish
JournalCephalalgia : an international journal of headache
Pages (from-to)epub
ISSN0333-1024
DOIs
Publication statusE-pub ahead of print - 2019
Externally publishedYes

ID: 58348831